Differences in thrombolytic treatment and in-hospital mortality between women and men after acute myocardial infarction

Japanese Heart Journal
Mohammad ZubaidC G Suresh

Abstract

There is evidence for gender differences in the treatment and outcome of acute myocardial infarction (AMI). However, little data exist about these differences in patients from the Arab Middle East. Therefore, we studied the influence of patient gender on the presentation, the use of thrombolytic therapy, and in-hospital mortality after AMI in Kuwaiti nationals. This is a retrospective study of all consecutive Kuwaiti patients admitted to the coronary care unit of a university hospital with the diagnosis of AMI between June 1994 and May 1997. A total of 89 women and 267 men were included. Women were older than men and had significantly higher rates of diabetes (72% vs 46%), hypertension (58% vs 33%) and hypercholesterolemia (80% vs 53%). Women were less likely to receive thrombolytic therapy (40% vs 62%, p=0.001). Fewer women were eligible for thrombolytic therapy (50% vs 66%, p<0.05). Of those who were eligible for thrombolysis there was no sex difference in receiving such treatment. The in-hospital mortality among women younger than 70 years was 2.5 times higher than among men in the same age group, while there was no difference in mortality between women and men aged 70 years and older. We conclude that women and men with AMI...Continue Reading

References

Aug 15, 1991·The American Journal of Cardiology·C MaynardJ W Kennedy
Jul 25, 1991·The New England Journal of Medicine·J Z Ayanian, A M Epstein
Dec 16, 1988·JAMA : the Journal of the American Medical Association·R D AbbottP W Wilson
Jun 1, 1995·The American Journal of Cardiology·J DemirovicD Gilbertson
Feb 15, 1994·The American Journal of Cardiology·J S JenkinsG F Petroski
Jun 1, 1997·Journal of the American College of Cardiology·B E CoronadoH P Selker
Jun 23, 1997·Archives of Internal Medicine·C MaynardW D Weaver
Apr 1, 1998·Archives of Internal Medicine·J R Sowers
Mar 9, 2000·Acta Cardiologica·A al-AdsaniG Baidas
Jul 7, 2000·The New England Journal of Medicine·S C GanL Chan

❮ Previous
Next ❯

Citations

Mar 14, 2007·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Louise PiloteVicky Tagalakis
Apr 22, 2009·Expert Review of Cardiovascular Therapy·Ayman A El-Menyar, Jassim Al Suwaidi
Apr 24, 2014·Expert Review of Cardiovascular Therapy·Rafid Fayadh Al-Aqeedi, Jassim Al Suwaidi
Oct 6, 2009·The American Journal of Cardiology·Ayman El-MenyarJassim Al Suwaidi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.